LD-2 disclosure · 2nd Quarter - Report
GENETIX BIOTHERAPEUTICS, INC.
Client
- Name
- GENETIX BIOTHERAPEUTICS, INC.
- Description
- Biotechnology and pharmaceutical company.
- Location
- Massachusetts · United States of America
Registrant
- Description
- Law firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesMedicare/Medicaid
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Legislation related to antikickback exclusions for travel and lodging arrangements between manufacturers of drugs and patients
LobbyistsEUGENIA PIERSON · BOBBY MCMILLIN · SONJA NESBIT · RON KIND · LUKE ALBERT · LEIGH ANN FAIRLEY
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Health & Human Services, Dept of (HHS)
Health Issues
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Legislation related to antikickback exclusions for travel and lodging arrangements between manufacturers of drugs and patients
LobbyistsEUGENIA PIERSON · BOBBY MCMILLIN · SONJA NESBIT · RON KIND · LUKE ALBERT · LEIGH ANN FAIRLEY
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Health & Human Services, Dept of (HHS)